BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12874229)

  • 1. Functional analysis of the TCR binding domain of toxic shock syndrome toxin-1 predicts further diversity in MHC class II/superantigen/TCR ternary complexes.
    McCormick JK; Tripp TJ; Llera AS; Sundberg EJ; Dinges MM; Mariuzza RA; Schlievert PM
    J Immunol; 2003 Aug; 171(3):1385-92. PubMed ID: 12874229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
    Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the T cell receptor alpha chain in stabilizing TCR-superantigen-MHC class II complexes.
    Andersen PS; Lavoie PM; Sékaly RP; Churchill H; Kranz DM; Schlievert PM; Karjalainen K; Mariuzza RA
    Immunity; 1999 Apr; 10(4):473-83. PubMed ID: 10229190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
    Kum WW; Laupland KB; Chow AW
    Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1.
    Buonpane RA; Moza B; Sundberg EJ; Kranz DM
    J Mol Biol; 2005 Oct; 353(2):308-21. PubMed ID: 16171815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.
    Hurley JM; Shimonkevitz R; Hanagan A; Enney K; Boen E; Malmstrom S; Kotzin BL; Matsumura M
    J Exp Med; 1995 Jun; 181(6):2229-35. PubMed ID: 7760008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of a T-cell receptor beta-chain complexed with a superantigen.
    Fields BA; Malchiodi EL; Li H; Ysern X; Stauffacher CV; Schlievert PM; Karjalainen K; Mariuzza RA
    Nature; 1996 Nov; 384(6605):188-92. PubMed ID: 8906797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The T cell receptor beta-chain second complementarity determining region loop (CDR2beta governs T cell activation and Vbeta specificity by bacterial superantigens.
    Nur-ur Rahman AK; Bonsor DA; Herfst CA; Pollard F; Peirce M; Wyatt AW; Kasper KJ; Madrenas J; Sundberg EJ; McCormick JK
    J Biol Chem; 2011 Feb; 286(6):4871-81. PubMed ID: 21127057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of T-cell specificity and activation by the bacterial superantigen TSST-1.
    Moza B; Varma AK; Buonpane RA; Zhu P; Herfst CA; Nicholson MJ; Wilbuer AK; Seth NP; Wucherpfennig KW; McCormick JK; Kranz DM; Sundberg EJ
    EMBO J; 2007 Feb; 26(4):1187-97. PubMed ID: 17268555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural dichotomy of staphylococcal enterotoxin C superantigens leading to MHC class II-independent activation of T lymphocytes.
    Lamphear JG; Bohach GA; Rich RR
    J Immunol; 1998 Mar; 160(5):2107-14. PubMed ID: 9498747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different superantigens interact with distinct sites in the Vbeta domain of a single T cell receptor.
    Hong SC; Waterbury G; Janeway CA
    J Exp Med; 1996 Apr; 183(4):1437-46. PubMed ID: 8666902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vbeta8.2.
    Fernández MM; Bhattacharya S; De Marzi MC; Brown PH; Kerzic M; Schuck P; Mariuzza RA; Malchiodi EL
    Proteins; 2007 Jul; 68(1):389-402. PubMed ID: 17427250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel loop domain in superantigens extends their T cell receptor recognition site.
    Günther S; Varma AK; Moza B; Kasper KJ; Wyatt AW; Zhu P; Rahman AK; Li Y; Mariuzza RA; McCormick JK; Sundberg EJ
    J Mol Biol; 2007 Aug; 371(1):210-21. PubMed ID: 17560605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structural basis of T cell activation by superantigens.
    Li H; Llera A; Malchiodi EL; Mariuzza RA
    Annu Rev Immunol; 1999; 17():435-66. PubMed ID: 10358765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
    Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
    Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules.
    Soos JM; Russell JK; Jarpe MA; Pontzer CH; Johnson HM
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1211-7. PubMed ID: 8466498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of MHC class II-associated peptides that promote the presentation of toxic shock syndrome toxin-1 to T cells.
    Hogan RJ; VanBeek J; Broussard DR; Surman SL; Woodland DL
    J Immunol; 2001 Jun; 166(11):6514-22. PubMed ID: 11359802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes.
    Arcus VL; Proft T; Sigrell JA; Baker HM; Fraser JD; Baker EN
    J Mol Biol; 2000 May; 299(1):157-68. PubMed ID: 10860729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of a biologically inactive mutant of toxic shock syndrome toxin-1 at 2.5 A resolution.
    Papageorgiou AC; Quinn CP; Beer D; Brehm RD; Tranter HS; Bonventre PF; Acharya KR
    Protein Sci; 1996 Aug; 5(8):1737-41. PubMed ID: 8844860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens.
    Labrecque N; Thibodeau J; Mourad W; Sékaly RP
    J Exp Med; 1994 Nov; 180(5):1921-9. PubMed ID: 7964467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.